The European Association of Urology (EAU) and the European School of Urology (ESU) officially introduced the new e-course on Metastatic Prostate Cancer (mPCa) today at the 8th European Multidisciplinary Meeting on Urological Cancers (EMUC16). Chair of the ESU, Prof. J. Palou (ES) and Prof. Dr. N. Mottet (FR) gave an overview of the learning objectives of the e-course, as well as, its interactive features.
The e-course offers a complete overview of the clinical aspects, diagnosis, and treatment of castrate-sensitive mPCa which are aligned with the EAU Guidelines. The objectives of the course include definition of castrate-sensitive and castrate-resistant mPCa, detection of suspicious symptoms in a case of known or unknown PCa, and selection of imaging technology on a case-to-case basis. The e-course also aims for the study of the molecular mechanisms of various treatments, clinical and biological follow-up and monitoring of mPCa patients, and how to use nomograms to determine the prognosis of the patient.
The mPCA e-course begins with a pre-test to assist with the learning process. Upon completion of the pre-test, the examinee will be granted access to two modules: Learning Module A (Metastatic PCa) and Learning Module B (Castrate Resistant PCa). Each module has a duration of approximately 90 minutes. The final tests are found at the end of each module. After each test, the scores will be calculated. The examinee should answer 80% of the answers correctly to pass but will be given opportunity to re-take.
The lecturers who contributed to the development of the e-course are namely Prof. Dr. N. Mottet (EAU Guidelines on Prostate Cancer Chairman) of CHU St. Etienne, and Prof. Dr. A.S. Mersebruger of the University Hospital Schleswig-Holstein, as main authors, along with Dr. M.C. Hupe of the University Hospital Schleswig-Holstein, Dr. V. Soulier of the CHU St. Etienne, and Prof. M.J. Drake (ESU board member) as Medical Coordinator.